tradingkey.logo

Biomerica Inc

BMRA
View Detailed Chart

3.200USD

+0.070+2.24%
Market hours ETQuotes delayed by 15 min
8.15MMarket Cap
LossP/E TTM

Biomerica Inc

3.200

+0.070+2.24%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.24%

5 Days

-18.16%

1 Month

-2.14%

6 Months

-14.98%

Year to Date

+33.29%

1 Year

+45.19%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(3)
Buy(0)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.050
Neutral
RSI(14)
45.140
Neutral
STOCH(KDJ)(9,3,3)
15.194
Sell
ATR(14)
0.277
High Vlolatility
CCI(14)
-93.121
Neutral
Williams %R
77.515
Sell
TRIX(12,20)
0.477
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
3.438
Sell
MA10
3.587
Sell
MA20
3.421
Sell
MA50
3.310
Sell
MA100
3.757
Sell
MA200
3.702
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Ticker SymbolBMRA
CompanyBiomerica Inc
CEOMr. Zackary S. Irani
Websitehttps://biomerica.com/
KeyAI